硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 TRAF3IP2 抗体对
试剂盒

人 TRAF3IP2 抗体对

01AB02701

TRAF3 interacting protein 2 (TRAF3IP2), also known as ACT1 or CIKS, is a cytoplasmic adaptor and E3 ubiquitin ligase that mediates Lys63-linked polyubiquitination to facilitate protein-protein interactions. It is a central component of the IL-17A signaling pathway, where it binds to IL17RA/RC receptors via SEFIR domains and recruits TRAF6 to activate canonical NF-kappaB and MAPK pathways. This signaling is vital for regulating cytokine responses in innate and adaptive immunity. Clinically, germline variants in TRAF3IP2 are associated with psoriasis 13 and psoriatic arthritis, driven by dysregulated IL-17 signaling. Furthermore, loss-of-function mutations cause familial candidiasis 8 due to impaired antifungal immunity, while experimental evidence also links the protein to vascular insulin resistance and hypertension.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
TRAF3IP2
基因别名
C6orf2; C6orf4; C6orf5; C6orf6
蛋白别名
TRAF3 interacting protein 2; TRAF3IP2
UniProt
O43734
物种
Human

产品详情

靶点名称
TRAF3IP2
蛋白名称
TRAF3 interacting protein 2
蛋白别名
E3 ubiquitin ligase TRAF3IP2; Adapter protein CIKS; Connection to IKK and SAPK/JNK; E3 ubiquitin-protein ligase CIKS; Nuclear factor NF-kappa-B activator 1; ACT1; TRAF3-interacting protein 2
靶点基因名
TRAF3IP2
基因别名
C6orf2; C6orf4; C6orf5; C6orf6
UniProt
O43734
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

TRAF3 interacting protein 2 (TRAF3IP2), also known as ACT1 or CIKS, is a cytoplasmic adaptor and E3 ubiquitin ligase that mediates Lys63-linked polyubiquitination to facilitate protein-protein interactions. It is a central component of the IL-17A signaling pathway, where it binds to IL17RA/RC receptors via SEFIR domains and recruits TRAF6 to activate canonical NF-kappaB and MAPK pathways. This signaling is vital for regulating cytokine responses in innate and adaptive immunity. Clinically, germline variants in TRAF3IP2 are associated with psoriasis 13 and psoriatic arthritis, driven by dysregulated IL-17 signaling. Furthermore, loss-of-function mutations cause familial candidiasis 8 due to impaired antifungal immunity, while experimental evidence also links the protein to vascular insulin resistance and hypertension.